Nicardipine enhances the effect of cyclosporine A on T lymphocyte activation in vitro.
D003524:Cyclosporins / Q000008:administration & dosage*; D004357:Drug Synergism; D006801:Humans; D066298:In Vitro Techniques; D007376:Interleukin-2 / Q000096:biosynthesis / Q000494:pharmacology; D008213:Lymphocyte Activation / Q000187:drug effects*; D009529:Nicardipine / Q000008:administration & dosage*; D010835:Phytohemagglutinins / Q000494:pharmacology; D011971:Receptors, Immunologic / Q000378:metabolism; D015375:Receptors, Interleukin-2; D013601:T-Lymphocytes / Q000276:immunology*
D003524:Cyclosporins; D007376:Interleukin-2; D010835:Phytohemagglutinins; D011971:Receptors, Immunologic; D015375:Receptors, Interleukin-2; D009529:Nicardipine